Home | Add Company | Subscribe | Search | Contact

BioPharmaLink

 

Login

Directory:

Add Company

Your company can benefit from enhanced listings. Questions? Read our FAQ first.

 

Personalized notification service and newsletter info

Subscribe (free) to get notified of new additions.

 

Learn more About us and about our Services

 

Contact us

Naproxen

Readily available EU registration dossier

Offer available for: licensing

Pharmaceutical form and dosage: 250-500 mg Tablets


Type:

- Generics
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)


Therapeutic target:

- Arthritis / Rheumato
- Dermatology

Action: Anti-inflammatory (Dermato) and antirheumatic products - analgesics. (Rheumato)

Company Contact


Corporate data: PharmaRegistrations
Belgium

Contact for this offer: Lieve Vermassen

Or check this company's:


Full Description:
Naproxen dossier:
-Readily available for licensing
-Marketing Authorization obtained in Belgium and The Netherlands (we can also register in other countries)
-Stability: 25C: 30 months


Availability and Market information:

Status: Registered (MA obtained)

Market(s) and Registration Info: (date: concerns Marketing Authorization)
- Belgium : 2000
- Netherlands
Registration info: On request: registration in other countries


Market information

Other Market Info:


Patent Information:
Name: Naprosyne
Patent info: Expired


Suggestion box | Disclaimer | Privacy Policy | Rules & Regulations
Copyright© Cofidei, Inc. Last modified: 31-Oct-2001.

Home | Add Company | Subscribe to Newsletter | Search Companies | Search Offers | Power search